These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16750039)

  • 1. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
    Shen G; Chai Y; Yue L; Wei HQ; Lin M
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential role of bcl-2, bax, and Ki67 expression in thymus of patients with myasthenia gravis, and their correlation with clinicopathologic parameters.
    Salakou S; Tsamandas AC; Bonikos DS; Papapetropoulos T; Dougenis D
    Eur J Cardiothorac Surg; 2001 Oct; 20(4):712-21. PubMed ID: 11574213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
    Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
    In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.
    Bouchikh M; Zouaidia F; Benhaddou EHA; Mahassini N; Achir A; El Malki HO
    Rev Neurol (Paris); 2017 Jun; 173(6):388-395. PubMed ID: 28461027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
    Zhang Y; Yu L; Jing Y; Ke J
    Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
    Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
    Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma.
    Chen P; Wang YP; Mou DL; Li ZY; Qu QM; Wang HY; Deng Y; Li XF; Wang T; Xu XH; Zhao G
    Pathol Oncol Res; 2018 Jan; 24(1):67-74. PubMed ID: 28299711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
    Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
    Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different characteristics of thymomas with and without myasthenia gravis.
    Yu L; Zhang XJ; Ma S; Jing Y; Li F; Krasna MJ
    Ann Surg Oncol; 2012 Jan; 19(1):94-8. PubMed ID: 21879277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience.
    Ruffini E; Filosso PL; Mossetti C; Bruna MC; Novero D; Lista P; Casadio C; Oliaro A
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):146-53. PubMed ID: 21093283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
    Xue L; Wang L; Dong J; Yuan Y; Fan H; Zhang Y; Wang Q; Ding J
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):692-697. PubMed ID: 29156018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between expression of Cat V and clinicopathologic character of myasthenia gravis in patients with thymoma].
    Wang Y; Huang Y; Luo DY; Yuan O; Gong RR; Qiu GD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):886-8. PubMed ID: 17236586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymectomy.
    Nicolaou S; Müller NL; Li DK; Oger JJ
    Radiology; 1996 Nov; 201(2):471-4. PubMed ID: 8888243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
    Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
    J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary treated thymomas with fatal outcome. A retrospective study.
    Ionescu L; Dănilă R; Timofte D; Butcovan D; Stefanescu C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):675-8. PubMed ID: 25341283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
    Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
    J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical therapy of myasthenia gravis and thymoma].
    Bertram P; Treutner KH; Winkeltau G; Schumpelick V
    Chirurg; 1993 Oct; 64(10):796-801. PubMed ID: 8269744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.